Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's Pre-Market Session

Author: Benzinga Insights | November 08, 2024 07:05am

Gainers

  • Tivic Health Systems (NASDAQ:TIVC) shares rose 127.3% to $0.59 during Friday's pre-market session. The market value of their outstanding shares is at $3.6 million.
  • Doximity (NYSE:DOCS) stock moved upwards by 39.82% to $60.71. The market value of their outstanding shares is at $11.2 billion. As per the news, the Q2 earnings report came out yesterday.
  • Xilio Therapeutics (NASDAQ:XLO) stock moved upwards by 14.42% to $1.19. The market value of their outstanding shares is at $52.3 million. As per the news, the Q3 earnings report came out yesterday.
  • Eyenovia (NASDAQ:EYEN) shares increased by 13.97% to $0.55. The market value of their outstanding shares is at $47.4 million.
  • Fortrea Holdings (NASDAQ:FTRE) shares rose 13.68% to $20.52. The market value of their outstanding shares is at $1.8 billion. The company's, Q3 earnings came out today.
  • CytomX Therapeutics (NASDAQ:CTMX) shares moved upwards by 12.99% to $1.13. The market value of their outstanding shares is at $88.2 million. As per the news, the Q3 earnings report came out yesterday.

Losers

  • ProPhase Labs (NASDAQ:PRPH) shares declined by 51.0% to $0.7 during Friday's pre-market session. The market value of their outstanding shares is at $13.3 million.
  • Evolent Health (NYSE:EVH) stock decreased by 35.5% to $15.85. The market value of their outstanding shares is at $1.8 billion. As per the press release, Q3 earnings came out yesterday.
  • Agilon Health (NYSE:AGL) shares fell 31.9% to $1.9. The company's market cap stands at $781.8 million. As per the news, the Q3 earnings report came out yesterday.
  • Maravai LifeSciences (NASDAQ:MRVI) shares declined by 28.19% to $5.63. The market value of their outstanding shares is at $796.9 million. As per the news, the Q3 earnings report came out yesterday.
  • Revance Therapeutics (NASDAQ:RVNC) shares fell 15.23% to $4.9. The market value of their outstanding shares is at $510.4 million. As per the press release, Q3 earnings came out yesterday.
  • AlloVir (NASDAQ:ALVR) shares fell 14.42% to $0.84. The company's market cap stands at $96.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AGL ALVR CTMX DOCS EVH EYEN FTRE MRVI PRPH RVNC TIVC XLO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist